rs34533941
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_000518.5(HBB):c.282_283dupTG(p.Asp95ValfsTer65) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Consequence
NM_000518.5 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 36
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Beta zero thalassemia Pathogenic:1
- -
Dominant beta-thalassemia Pathogenic:1
The heterozygous p.Asp95ValfsTer65 variant in HBB was identified by our study in one individual with beta-thalassemia. The p.Asp95ValfsTer65 variant in HBB has been previously reported in one individual with beta-thalassemia (PMID: 2291578). This variant has also been reported in ClinVar (Variation ID: 15428) and has been interpreted by OMIM as pathogenic. This variant was absent from large population studies. This variant is predicted to cause a frameshift, which alters the protein’s amino acid sequence beginning at position 95 and leads to a premature termination codon 65 amino acids downstream. This termination codon occurs within the terminal 50 bases of the last exon and is more likely to escape nonsense mediated decay (NMD) and result in a truncated protein. Heterozygous loss of function of the HBB gene is an established disease mechanism in autosomal dominant beta-thalassemia. In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic for autosomal dominant beta-thalassemia. ACMG/AMP Criteria applied: PVS1_Strong, PM2_Supporting, PS4_Supporting (Richards 2015). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at